ID   LOX1_SOYBN              Reviewed;         839 AA.
AC   P08170;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 2.
DT   07-APR-2021, entry version 180.
DE   RecName: Full=Seed linoleate 13S-lipoxygenase-1;
DE            EC=1.13.11.12 {ECO:0000269|PubMed:16157595, ECO:0000269|PubMed:2492826};
DE   AltName: Full=Lipoxygenase-1;
DE            Short=L-1;
GN   Name=LOX1.1; Synonyms=LOX1;
OS   Glycine max (Soybean) (Glycine hispida).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; fabids; Fabales; Fabaceae; Papilionoideae; 50 kb inversion clade;
OC   NPAAA clade; indigoferoid/millettioid clade; Phaseoleae; Glycine;
OC   Glycine subgen. Soja.
OX   NCBI_TaxID=3847;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3112136;
RA   Shibata D., Steczko J., Dixon J.E., Hermodson M., Yazdanparast R.,
RA   Axelrod B.;
RT   "Primary structure of soybean lipoxygenase-1.";
RL   J. Biol. Chem. 262:10080-10085(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Bonminori; TISSUE=Cotyledon;
RA   Fukazawa C., Masayoshi M., Chikafusa F.;
RL   Submitted (JUN-1992) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 426-752.
RX   AGRICOLA=IND87003970; DOI=10.1007/BF00020127;
RA   Start W.G., Ma Y., Polacco J.C., Hildebrand D.F., Freyer G.A.,
RA   Altschuler M.;
RT   "Two soybean seed lipoxygenase nulls accumulate reduced levels of
RT   lipoxygenase transcripts.";
RL   Plant Mol. Biol. 7:11-23(1986).
RN   [4]
RP   SEQUENCE REVISION TO 479-482, AND MUTAGENESIS OF SOME HISTIDINE RESIDUES.
RX   PubMed=1567851; DOI=10.1021/bi00131a022;
RA   Steczko J., Donoho G.P., Clemens J.C., Dixon J.E., Axelrod B.;
RT   "Conserved histidine residues in soybean lipoxygenase: functional
RT   consequences of their replacement.";
RL   Biochemistry 31:4053-4057(1992).
RN   [5]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SPECIFICITY.
RX   PubMed=2492826; DOI=10.1016/0005-2760(89)90111-2;
RA   Gardner H.W.;
RT   "Soybean lipoxygenase-1 enzymically forms both (9S)- and (13S)-
RT   hydroperoxides from linoleic acid by a pH-dependent mechanism.";
RL   Biochim. Biophys. Acta 1001:274-281(1989).
RN   [6]
RP   MUTAGENESIS OF SOME HISTIDINE RESIDUES.
RX   PubMed=1497657; DOI=10.1016/0006-291x(92)90801-q;
RA   Steczko J., Axelrod B.;
RT   "Identification of the iron-binding histidine residues in soybean
RT   lipoxygenase L-1.";
RL   Biochem. Biophys. Res. Commun. 186:686-689(1992).
RN   [7]
RP   COFACTOR.
RX   PubMed=8518276; DOI=10.1021/bi00076a003;
RA   Minor W., Steczko J., Bolin J.T., Otwinowski Z., Axelrod B.;
RT   "Crystallographic determination of the active site iron and its ligands in
RT   soybean lipoxygenase L-1.";
RL   Biochemistry 32:6320-6323(1993).
RN   [8]
RP   CATALYTIC ACTIVITY, FUNCTION, MUTAGENESIS OF ALA-542, ENZYME KINETICS,
RP   REACTION MECHANISM, AND EPR SPECTROSCOPY.
RX   PubMed=16157595; DOI=10.1074/jbc.m504870200;
RA   Coffa G., Imber A.N., Maguire B.C., Laxmikanthan G., Schneider C.,
RA   Gaffney B.J., Brash A.R.;
RT   "On the relationships of substrate orientation, hydrogen abstraction, and
RT   product stereochemistry in single and double dioxygenations by soybean
RT   lipoxygenase-1 and its Ala542Gly mutant.";
RL   J. Biol. Chem. 280:38756-38766(2005).
RN   [9]
RP   CATALYTIC ACTIVITY.
RX   PubMed=19324874; DOI=10.1074/jbc.m809014200;
RA   Dangi B., Obeng M., Nauroth J.M., Teymourlouei M., Needham M., Raman K.,
RA   Arterburn L.M.;
RT   "Biogenic synthesis, purification, and chemical characterization of anti-
RT   inflammatory resolvins derived from docosapentaenoic acid (DPAn-6).";
RL   J. Biol. Chem. 284:14744-14759(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH IRON IONS.
RX   PubMed=8502991; DOI=10.1126/science.8502991;
RA   Boyington J.C., Gaffney B.J., Amzel L.M.;
RT   "The three-dimensional structure of an arachidonic acid 15-lipoxygenase.";
RL   Science 260:1482-1486(1993).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) IN COMPLEX WITH IRON IONS.
RX   PubMed=8718858; DOI=10.1021/bi960576u;
RA   Minor W., Steczko J., Stec B., Otwinowski Z., Bolin J.T., Walter R.,
RA   Axelrod B.;
RT   "Crystal structure of soybean lipoxygenase L-1 at 1.4-A resolution.";
RL   Biochemistry 35:10687-10701(1996).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF WILD-TYPE AND MUTANTS GLN-495 AND
RP   GLN-697 IN COMPLEX WITH IRON IONS, AND MUTAGENESIS OF GLN-495 AND GLN-697.
RX   PubMed=11412104; DOI=10.1021/bi002893d;
RA   Tomchick D.R., Phan P., Cymborowski M., Minor W., Holman T.R.;
RT   "Structural and functional characterization of second-coordination sphere
RT   mutants of soybean lipoxygenase-1.";
RL   Biochemistry 40:7509-7517(2001).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) IN COMPLEX WITH IRON IONS, AND
RP   MUTAGENESIS OF ASN-694.
RX   PubMed=16922498; DOI=10.1021/bi060577e;
RA   Segraves E.N., Chruszcz M., Neidig M.L., Ruddat V., Zhou J., Wecksler A.T.,
RA   Minor W., Solomon E.I., Holman T.R.;
RT   "Kinetic, spectroscopic, and structural investigations of the soybean
RT   lipoxygenase-1 first-coordination sphere mutant, Asn694Gly.";
RL   Biochemistry 45:10233-10242(2006).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) IN COMPLEX WITH IRON IONS.
RX   PubMed=18441029; DOI=10.1529/biophysj.108.131789;
RA   Chruszcz M., Wlodawer A., Minor W.;
RT   "Determination of protein structures--a series of fortunate events.";
RL   Biophys. J. 95:1-9(2008).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) IN COMPLEX WITH IRON IONS, AND
RP   MUTAGENESIS OF ILE-553.
RX   PubMed=18216254; DOI=10.1073/pnas.0710643105;
RA   Meyer M.P., Tomchick D.R., Klinman J.P.;
RT   "Enzyme structure and dynamics affect hydrogen tunneling: the impact of a
RT   remote side chain (I553) in soybean lipoxygenase-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:1146-1151(2008).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH IRON IONS, AND
RP   MUTAGENESIS OF LEU-546 AND LEU-754.
RX   PubMed=24884374; DOI=10.1021/ja502726s;
RA   Hu S., Sharma S.C., Scouras A.D., Soudackov A.V., Carr C.A.,
RA   Hammes-Schiffer S., Alber T., Klinman J.P.;
RT   "Extremely elevated room-temperature kinetic isotope effects quantify the
RT   critical role of barrier width in enzymatic C-H activation.";
RL   J. Am. Chem. Soc. 136:8157-8160(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS).
RX   PubMed=28691068; DOI=10.1021/acscentsci.7b00142;
RA   Offenbacher A.R., Hu S., Poss E.M., Carr C.A.M., Scouras A.D.,
RA   Prigozhin D.M., Iavarone A.T., Palla A., Alber T., Fraser J.S.,
RA   Klinman J.P.;
RT   "Hydrogen-deuterium exchange of lipoxygenase uncovers a relationship
RT   between distal, solvent exposed protein motions and the thermal activation
RT   barrier for catalytic proton-coupled electron tunneling.";
RL   ACS Cent. Sci. 3:570-579(2017).
CC   -!- FUNCTION: Plant lipoxygenase may be involved in a number of diverse
CC       aspects of plant physiology including growth and development, pest
CC       resistance, and senescence or responses to wounding. With linoleate as
CC       substrate, L-1 shows a preference for carbon 13 as the site for
CC       hydroperoxidation (in contrast to L-2 and L-3, which utilize either
CC       carbon 9 or 13). At pH above 8.5, only (9Z,11E,13S)-13-
CC       hydroperoxyoctadeca-9,11-dienoate is produced, but as the pH decreases,
CC       the proportion of (9S)-hydroperoxide increases linearly until at pH 6.0
CC       it represents about 25 % of the products.
CC       {ECO:0000269|PubMed:16157595}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoate + O2 = (13S)-hydroperoxy-(9Z,11E)-
CC         octadecadienoate; Xref=Rhea:RHEA:22780, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:57466; EC=1.13.11.12;
CC         Evidence={ECO:0000269|PubMed:16157595, ECO:0000269|PubMed:2492826};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoate + O2 = (13S)-hydroperoxy-
CC         (9Z,11E,15Z)-octadecatrienoate; Xref=Rhea:RHEA:34495,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:32387, ChEBI:CHEBI:58757;
CC         EC=1.13.11.12; Evidence={ECO:0000269|PubMed:16157595,
CC         ECO:0000269|PubMed:2492826};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 = (17S)-
CC         hydroperoxy-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoate;
CC         Xref=Rhea:RHEA:50840, ChEBI:CHEBI:15379, ChEBI:CHEBI:77016,
CC         ChEBI:CHEBI:133795; Evidence={ECO:0000269|PubMed:19324874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50841;
CC         Evidence={ECO:0000269|PubMed:19324874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate + O2 = (17S)-
CC         hydroperoxy-(4Z,7Z,10Z,13Z,15E)-docosapentaenoate;
CC         Xref=Rhea:RHEA:50828, ChEBI:CHEBI:15379, ChEBI:CHEBI:77226,
CC         ChEBI:CHEBI:133796; Evidence={ECO:0000269|PubMed:19324874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50829;
CC         Evidence={ECO:0000269|PubMed:19324874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(7Z,10Z,13Z,16Z,19Z)-docosapentaenoate + O2 = 17-hydroperoxy-
CC         (7Z,10Z,13Z,15E,19Z)-docosapentaenoate; Xref=Rhea:RHEA:50832,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:77224, ChEBI:CHEBI:133797;
CC         Evidence={ECO:0000269|PubMed:19324874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50833;
CC         Evidence={ECO:0000269|PubMed:19324874};
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00726,
CC         ECO:0000269|PubMed:8518276};
CC       Note=Binds 1 Fe cation per subunit. Iron is tightly bound.
CC       {ECO:0000255|PROSITE-ProRule:PRU00726, ECO:0000269|PubMed:8518276};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Inactive below pH 6.0. {ECO:0000269|PubMed:2492826};
CC   -!- PATHWAY: Lipid metabolism; oxylipin biosynthesis. {ECO:0000255|PROSITE-
CC       ProRule:PRU00726}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11412104,
CC       ECO:0000269|PubMed:8502991, ECO:0000269|PubMed:8718858}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- INDUCTION: The hydroperoxide product serves to activate the resting
CC       enzyme. The activation is accompanied by the oxidation of
CC       Fe(2+)entadiene structure. L-1 prefers anionic substrate.
CC   -!- MISCELLANEOUS: Soybean contains at least 4 distinct isoenzymes, L-1, L-
CC       2, L-3a and L-3b in dry seeds, and at least two distinct isozymes in
CC       the hypocotyl/radicle region of the seedling stem.
CC   -!- SIMILARITY: Belongs to the lipoxygenase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA47717.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02795; AAA33986.1; -; mRNA.
DR   EMBL; X67304; CAA47717.1; ALT_FRAME; mRNA.
DR   PIR; S25064; DASYL2.
DR   RefSeq; NP_001236153.1; NM_001249224.1.
DR   PDB; 1F8N; X-ray; 1.40 A; A=1-839.
DR   PDB; 1FGM; X-ray; 1.90 A; A=1-839.
DR   PDB; 1FGO; X-ray; 1.62 A; A=1-839.
DR   PDB; 1FGQ; X-ray; 1.85 A; A=1-839.
DR   PDB; 1FGR; X-ray; 1.60 A; A=1-839.
DR   PDB; 1FGT; X-ray; 1.62 A; A=1-839.
DR   PDB; 1Y4K; X-ray; 1.95 A; A=1-839.
DR   PDB; 1YGE; X-ray; 1.40 A; A=1-839.
DR   PDB; 2SBL; X-ray; 2.60 A; A/B=1-839.
DR   PDB; 3BNB; X-ray; 1.45 A; A=1-839.
DR   PDB; 3BNC; X-ray; 1.65 A; A=1-839.
DR   PDB; 3BND; X-ray; 1.60 A; A=1-839.
DR   PDB; 3BNE; X-ray; 1.40 A; A=1-839.
DR   PDB; 3PZW; X-ray; 1.40 A; A=1-839.
DR   PDB; 4WFO; X-ray; 1.14 A; A=1-839.
DR   PDB; 4WHA; X-ray; 1.70 A; A=1-839.
DR   PDB; 5EEO; X-ray; 2.10 A; A=1-839.
DR   PDB; 5T5V; X-ray; 1.80 A; A/B=1-839.
DR   PDB; 5TQN; X-ray; 1.80 A; A/B=1-839.
DR   PDB; 5TQO; X-ray; 1.70 A; A/B=1-839.
DR   PDB; 5TQP; X-ray; 1.70 A; A/B=1-839.
DR   PDB; 5TR0; X-ray; 1.85 A; A/B=1-839.
DR   PDBsum; 1F8N; -.
DR   PDBsum; 1FGM; -.
DR   PDBsum; 1FGO; -.
DR   PDBsum; 1FGQ; -.
DR   PDBsum; 1FGR; -.
DR   PDBsum; 1FGT; -.
DR   PDBsum; 1Y4K; -.
DR   PDBsum; 1YGE; -.
DR   PDBsum; 2SBL; -.
DR   PDBsum; 3BNB; -.
DR   PDBsum; 3BNC; -.
DR   PDBsum; 3BND; -.
DR   PDBsum; 3BNE; -.
DR   PDBsum; 3PZW; -.
DR   PDBsum; 4WFO; -.
DR   PDBsum; 4WHA; -.
DR   PDBsum; 5EEO; -.
DR   PDBsum; 5T5V; -.
DR   PDBsum; 5TQN; -.
DR   PDBsum; 5TQO; -.
DR   PDBsum; 5TQP; -.
DR   PDBsum; 5TR0; -.
DR   SMR; P08170; -.
DR   STRING; 3847.GLYMA13G42320.1; -.
DR   BindingDB; P08170; -.
DR   ChEMBL; CHEMBL4586; -.
DR   DrugCentral; P08170; -.
DR   SwissLipids; SLP:000001639; -.
DR   PRIDE; P08170; -.
DR   GeneID; 547923; -.
DR   KEGG; gmx:547923; -.
DR   eggNOG; ENOG502QQSP; Eukaryota.
DR   InParanoid; P08170; -.
DR   OrthoDB; 385042at2759; -.
DR   SABIO-RK; P08170; -.
DR   UniPathway; UPA00382; -.
DR   EvolutionaryTrace; P08170; -.
DR   PRO; PR:P08170; -.
DR   Proteomes; UP000008827; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005506; F:iron ion binding; IDA:UniProtKB.
DR   GO; GO:0016165; F:linoleate 13S-lipoxygenase activity; IDA:UniProtKB.
DR   GO; GO:0102299; F:linolenate 9R-lipoxygenase activity; IDA:UniProtKB.
DR   GO; GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IBA:GO_Central.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0019395; P:fatty acid oxidation; IDA:UniProtKB.
DR   GO; GO:0034440; P:lipid oxidation; IBA:GO_Central.
DR   GO; GO:0031408; P:oxylipin biosynthetic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd01751; PLAT_LH2; 1.
DR   Gene3D; 4.10.372.10; -; 1.
DR   InterPro; IPR000907; LipOase.
DR   InterPro; IPR013819; LipOase_C.
DR   InterPro; IPR036226; LipOase_C_sf.
DR   InterPro; IPR020834; LipOase_CS.
DR   InterPro; IPR020833; LipOase_Fe_BS.
DR   InterPro; IPR001246; LipOase_plant.
DR   InterPro; IPR042057; Lipoxy_PLAT/LH2.
DR   InterPro; IPR027433; Lipoxygenase_dom_3.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR036392; PLAT/LH2_dom_sf.
DR   PANTHER; PTHR11771; PTHR11771; 1.
DR   Pfam; PF00305; Lipoxygenase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PRINTS; PR00087; LIPOXYGENASE.
DR   PRINTS; PR00468; PLTLPOXGNASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF48484; SSF48484; 1.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   PROSITE; PS00711; LIPOXYGENASE_1; 1.
DR   PROSITE; PS00081; LIPOXYGENASE_2; 1.
DR   PROSITE; PS51393; LIPOXYGENASE_3; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Dioxygenase; Direct protein sequencing;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Iron; Lipid biosynthesis;
KW   Lipid metabolism; Metal-binding; Oxidoreductase; Oxylipin biosynthesis;
KW   Reference proteome.
FT   CHAIN           1..839
FT                   /note="Seed linoleate 13S-lipoxygenase-1"
FT                   /id="PRO_0000220717"
FT   DOMAIN          16..145
FT                   /note="PLAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00152"
FT   DOMAIN          148..839
FT                   /note="Lipoxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726"
FT   METAL           499
FT                   /note="Iron; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726,
FT                   ECO:0000269|PubMed:8502991, ECO:0007744|PDB:2SBL"
FT   METAL           504
FT                   /note="Iron; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726,
FT                   ECO:0000269|PubMed:8502991, ECO:0007744|PDB:2SBL"
FT   METAL           690
FT                   /note="Iron; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726,
FT                   ECO:0000269|PubMed:8502991, ECO:0007744|PDB:2SBL"
FT   METAL           694
FT                   /note="Iron; catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00726,
FT                   ECO:0000269|PubMed:8502991, ECO:0007744|PDB:2SBL"
FT   METAL           839
FT                   /note="Iron; via carboxylate; catalytic"
FT                   /evidence="ECO:0000269|PubMed:8502991,
FT                   ECO:0007744|PDB:2SBL"
FT   MUTAGEN         494
FT                   /note="H->Q: 37% of wild-type activity."
FT   MUTAGEN         494
FT                   /note="H->S: 8% of wild-type activity."
FT   MUTAGEN         495
FT                   /note="Q->A: Reduces catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:11412104"
FT   MUTAGEN         495
FT                   /note="Q->E: No effect on catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:11412104"
FT   MUTAGEN         499
FT                   /note="H->Q: Inactive."
FT   MUTAGEN         504
FT                   /note="H->Q,S: Inactive."
FT   MUTAGEN         517
FT                   /note="H->Q: 33% of wild-type activity."
FT   MUTAGEN         522
FT                   /note="H->Q: 1% of wild-type activity."
FT   MUTAGEN         531
FT                   /note="H->Q: 20% of wild-type activity."
FT   MUTAGEN         542
FT                   /note="A->G: Changes reaction profile to produce almost
FT                   equal amounts of 13S- and 9R-hydroperoxyoctadecadienoate."
FT                   /evidence="ECO:0000269|PubMed:16157595"
FT   MUTAGEN         542
FT                   /note="A->S: Little effect on reaction profile."
FT                   /evidence="ECO:0000269|PubMed:16157595"
FT   MUTAGEN         542
FT                   /note="A->T,V: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:16157595"
FT   MUTAGEN         546
FT                   /note="L->A: Reduces catalytic efficiency more than 14000-
FT                   fold; when associated with A-754."
FT                   /evidence="ECO:0000269|PubMed:24884374"
FT   MUTAGEN         553
FT                   /note="I->G: Reduces catalytic efficiency 230-fold."
FT                   /evidence="ECO:0000269|PubMed:18216254"
FT   MUTAGEN         690
FT                   /note="H->Q: Inactive."
FT   MUTAGEN         694
FT                   /note="N->G: Reduces catalytic efficiency 5-fold."
FT                   /evidence="ECO:0000269|PubMed:16922498"
FT   MUTAGEN         697
FT                   /note="Q->N,E: Reduces catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:11412104"
FT   MUTAGEN         754
FT                   /note="L->A: Reduces catalytic efficiency more than 14000-
FT                   fold; when associated with A-546."
FT                   /evidence="ECO:0000269|PubMed:24884374"
FT   CONFLICT        426..427
FT                   /note="AK -> RN (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        558..560
FT                   /note="LPS -> AL (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        572..574
FT                   /note="KNW -> EL (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        641
FT                   /note="N -> P (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        741..748
FT                   /note="KLPTLISL -> SCRLSLAV (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   STRAND          7..16
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           17..19
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           24..26
FT                   /evidence="ECO:0007744|PDB:1YGE"
FT   HELIX           32..35
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          39..50
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          56..58
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          66..68
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          79..86
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           89..91
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          94..101
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          103..105
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          107..114
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           119..121
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          123..131
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           134..136
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          141..144
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           151..153
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           156..158
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           159..170
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   TURN            195..197
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           199..201
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          206..212
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           242..244
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           251..253
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           255..257
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           258..264
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           266..275
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           286..290
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           291..293
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           301..307
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           313..316
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          317..319
FT                   /evidence="ECO:0007744|PDB:1Y4K"
FT   STRAND          321..326
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           331..333
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           339..341
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           343..352
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          353..355
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          364..366
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           373..376
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           385..387
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           395..400
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          404..408
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           410..421
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          430..437
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          443..451
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          456..458
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          465..467
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           473..496
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           497..503
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           504..517
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           523..528
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           529..532
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           535..545
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           552..556
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           560..562
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           563..571
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           576..579
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           581..587
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          590..593
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          600..605
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           609..628
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           629..631
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           636..640
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           643..654
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   TURN            655..657
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           658..660
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          669..671
FT                   /evidence="ECO:0007744|PDB:1YGE"
FT   HELIX           672..686
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           688..694
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           697..701
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   TURN            704..706
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          718..720
FT                   /evidence="ECO:0007744|PDB:5TR0"
FT   HELIX           721..728
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           730..737
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           741..754
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           776..801
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           803..805
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   HELIX           806..809
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   TURN            810..814
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          826..828
FT                   /evidence="ECO:0007744|PDB:4WFO"
FT   STRAND          834..836
FT                   /evidence="ECO:0007744|PDB:4WFO"
SQ   SEQUENCE   839 AA;  94369 MW;  1586250ACD3E34A4 CRC64;
     MFSAGHKIKG TVVLMPKNEL EVNPDGSAVD NLNAFLGRSV SLQLISATKA DAHGKGKVGK
     DTFLEGINTS LPTLGAGESA FNIHFEWDGS MGIPGAFYIK NYMQVEFFLK SLTLEAISNQ
     GTIRFVCNSW VYNTKLYKSV RIFFANHTYV PSETPAPLVS YREEELKSLR GNGTGERKEY
     DRIYDYDVYN DLGNPDKSEK LARPVLGGSS TFPYPRRGRT GRGPTVTDPN TEKQGEVFYV
     PRDENLGHLK SKDALEIGTK SLSQIVQPAF ESAFDLKSTP IEFHSFQDVH DLYEGGIKLP
     RDVISTIIPL PVIKELYRTD GQHILKFPQP HVVQVSQSAW MTDEEFAREM IAGVNPCVIR
     GLEEFPPKSN LDPAIYGDQS SKITADSLDL DGYTMDEALG SRRLFMLDYH DIFMPYVRQI
     NQLNSAKTYA TRTILFLRED GTLKPVAIEL SLPHSAGDLS AAVSQVVLPA KEGVESTIWL
     LAKAYVIVND SCYHQLMSHW LNTHAAMEPF VIATHRHLSV LHPIYKLLTP HYRNNMNINA
     LARQSLINAN GIIETTFLPS KYSVEMSSAV YKNWVFTDQA LPADLIKRGV AIKDPSTPHG
     VRLLIEDYPY AADGLEIWAA IKTWVQEYVP LYYARDDDVK NDSELQHWWK EAVEKGHGDL
     KDKPWWPKLQ TLEDLVEVCL IIIWIASALH AAVNFGQYPY GGLIMNRPTA SRRLLPEKGT
     PEYEEMINNH EKAYLRTITS KLPTLISLSV IEILSTHASD EVYLGQRDNP HWTSDSKALQ
     AFQKFGNKLK EIEEKLVRRN NDPSLQGNRL GPVQLPYTLL YPSSEEGLTF RGIPNSISI
//
